PL360052A1 - Composition and method for stable injectable liquids - Google Patents

Composition and method for stable injectable liquids

Info

Publication number
PL360052A1
PL360052A1 PL00360052A PL36005200A PL360052A1 PL 360052 A1 PL360052 A1 PL 360052A1 PL 00360052 A PL00360052 A PL 00360052A PL 36005200 A PL36005200 A PL 36005200A PL 360052 A1 PL360052 A1 PL 360052A1
Authority
PL
Poland
Prior art keywords
composition
injectable liquids
stable injectable
stable
liquids
Prior art date
Application number
PL00360052A
Other languages
Polish (pl)
Inventor
Bruce Joseph Roser
De Castro Arcadio Garcia
James Maki
Original Assignee
Cambridge Biostability Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Biostability Ltd. filed Critical Cambridge Biostability Ltd.
Publication of PL360052A1 publication Critical patent/PL360052A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL00360052A 2000-10-13 2000-10-13 Composition and method for stable injectable liquids PL360052A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/028244 WO2002032402A1 (en) 2000-10-13 2000-10-13 Composition and method for stable injectable liquids

Publications (1)

Publication Number Publication Date
PL360052A1 true PL360052A1 (en) 2004-09-06

Family

ID=21741883

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00360052A PL360052A1 (en) 2000-10-13 2000-10-13 Composition and method for stable injectable liquids

Country Status (12)

Country Link
EP (1) EP1328255A1 (en)
JP (1) JP2004513093A (en)
KR (1) KR20030096224A (en)
CN (1) CN100339066C (en)
AU (2) AU1198601A (en)
CA (2) CA2689856C (en)
ES (1) ES2337252T3 (en)
MX (1) MXPA03003236A (en)
NO (1) NO20031706L (en)
PL (1) PL360052A1 (en)
PT (1) PT1452171E (en)
WO (1) WO2002032402A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1559433A4 (en) * 2002-10-22 2009-11-04 Dainippon Sumitomo Pharma Co Stabilized composition
JP2007001865A (en) * 2003-09-16 2007-01-11 Ltt Bio-Pharma Co Ltd Fine particle enclosing fat-soluble medicine, method for producing the same and preparation containing the same
AU2005232441B2 (en) 2004-04-13 2010-11-11 Cambridge Biostability Limited Liquids containing suspended glass particles
GB0408199D0 (en) * 2004-04-13 2004-05-19 Cambridge Biostability Ltd Liquids containing suspended sugar glass particles
GB2430880A (en) * 2005-10-04 2007-04-11 Cambridge Biostability Ltd Pharmaceutical compositions stabilized in glassy particles
GB0523638D0 (en) * 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients
US8946200B2 (en) 2006-11-02 2015-02-03 Southwest Research Institute Pharmaceutically active nanosuspensions
WO2009091017A1 (en) * 2008-01-18 2009-07-23 Asahi Kasei Pharma Corporation Stable pharmaceutical composition
US8404850B2 (en) 2008-03-13 2013-03-26 Southwest Research Institute Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors
US8722706B2 (en) 2008-08-15 2014-05-13 Southwest Research Institute Two phase bioactive formulations of bis-quaternary pyridinium oxime sulfonate salts
US8309134B2 (en) 2008-10-03 2012-11-13 Southwest Research Institute Modified calcium phosphate nanoparticle formation
WO2010146536A1 (en) 2009-06-18 2010-12-23 Koninklijke Philips Electronics N.V. Suspension of particles with drug
WO2011007327A2 (en) 2009-07-16 2011-01-20 Koninklijke Philips Electronics N.V. Suspension for therapeutic use and device for delivering said suspension
ES2362525B8 (en) 2009-10-08 2013-01-03 Azurebio, S.L. Medication formulation in the form of penetrating percutaneous needles.
US9028873B2 (en) 2010-02-08 2015-05-12 Southwest Research Institute Nanoparticles for drug delivery to the central nervous system
US9884498B2 (en) 2014-03-24 2018-02-06 Seiko Epson Corporation Tape printing device and tape printing system
RU2016141948A (en) * 2014-03-27 2018-04-27 Новартис Аг SPRAY DRIED DISPERSIONS OF SOLID-IN-OIL-IN-WATER OF ACTIVE PHARMACEUTICAL INGREDIENTS FOR INHALATION

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78151B (en) * 1982-04-05 1984-09-26 Alcon Lab Inc
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
WO1993018748A1 (en) * 1992-03-19 1993-09-30 Allergan, Inc. Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid
GB9705588D0 (en) * 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations
US6190701B1 (en) * 1999-03-17 2001-02-20 Peter M. Ronai Composition and method for stable injectable liquids

Also Published As

Publication number Publication date
AU2001211986B2 (en) 2007-04-26
EP1328255A1 (en) 2003-07-23
ES2337252T3 (en) 2010-04-22
NO20031706D0 (en) 2003-04-11
CA2424656A1 (en) 2002-04-25
AU1198601A (en) 2002-04-29
CN1527699A (en) 2004-09-08
KR20030096224A (en) 2003-12-24
PT1452171E (en) 2010-03-08
CA2689856C (en) 2013-09-24
CA2424656C (en) 2010-03-23
NO20031706L (en) 2003-04-11
CA2689856A1 (en) 2002-04-25
CN100339066C (en) 2007-09-26
MXPA03003236A (en) 2004-12-03
WO2002032402A1 (en) 2002-04-25
JP2004513093A (en) 2004-04-30

Similar Documents

Publication Publication Date Title
AU5752601A (en) Splice-region antisense composition and method
AU6275601A (en) Stable polymeric micelle-type drug composition and method for the preparation thereof
AU6832101A (en) Composition and method
GB0008264D0 (en) Novel method and compounds
AU4163402A (en) Composition and method
EP1426349A4 (en) Additive for cement composition and cement composition containing the same
AU1198601A (en) Composition and method for stable injectable liquids
IL148803A0 (en) Novel composition and method for stabilizing the same
HK1039883A1 (en) Composition and method for stabilising proanthocyanidin
AU6866701A (en) New pet food composition and method
EP1313477A4 (en) Compounds and methods
GB2372300B (en) Arrangement and method for avoiding overturning
EP1274424A4 (en) Compounds and methods
AU2001251083A1 (en) Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists
EP1351647A4 (en) Compositions and methods for treating hyperpigmentation
AU7311501A (en) Cosmetic composition and method
AU4215901A (en) Methods and compositions for immunoregulation
AU2001233932A1 (en) Method and composition
IL153487A0 (en) Pharmaceutical compositions and methods for use
EP1451068A4 (en) Container having splines and method for using same
IL153897A0 (en) Pharmaceutical compositions and methods for use
IL145220A0 (en) Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
AU2002239775A1 (en) Chemical-library composition and method
AU7220501A (en) Mortar composition and method
EP1343796A4 (en) Compounds and methods

Legal Events

Date Code Title Description
DISD Decisions on discontinuance of the proceedings of a derived patent or utility model

Ref document number: 376992

Country of ref document: PL